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Introductory Remarks. I
WILLIAM T. FRIEDEWALD, MD
National Heart, Lung, and Blood Institute, National Institutes
of Health
I speak on behalf of the National Heart, Lung, and Blood
Institute (NHLBI) when I say we are delighted to be a
cosponsor for this important and timely Bethesda Confer-
ence. As we have learned more about the problems of car-
diovascular disease in the elderly, the issues have become
more critical and now reflect an area of special research
interest for the NHLBI. The National Center for Health
Statistics (NCHS) estimated that in 1984 there were ap-
proximately 26 million people in the United States aged
::::65 years and living independently, that is, outside nursing
homes or other similar facilities. Eight percent of this elderly
population were black. Most were women; 59% in the age
group 65 to 74 years and up to 71% in the age group ::::85
years were women. In addition, the size of our elderly
population is growing dramatically, with an estimated in-
crease of 20% during the next decade alone.
Currently, more than half of the patients in hospitals each
year who are diagnosed as having an acute myocardial in-
farction are ::::65 years of age. This fraction can be expected
to increase significantly during the 1990s. Even though over-
all coronary heart disease mortality rates in the United States
declined dramatically during the 1970s, the rates for those
aged >65 years have not shown the high rates of decline
observed for younger members of our society.
NHLBI-sponsored and cosponsored programs such as the
Systolic Hypertension in the Elderly Program, the Beta-
blocker Heart Attack Trial, the Framingham Heart Study
and the Coronary Artery Surgery Study all relate to the
important topic of this conference. More directly relevant,
however, is a working conference held last September by
the NHLBI on the topic of Recognition and Management
of Coronary Heart Disease in the Elderly (I). That confer-
ence came to several important conclusions and recom-
mendations. Briefly, it was felt that, although the U.S.
population aged ::::65 years encompasses the majority of
patients with coronary heart disease, scientific information
regarding the recognition of and current treatment ap-
proaches to the elderly coronary patient is inadequate or
lacking. It was also considered inappropriate to uncritically
extrapolate information obtained from younger persons to
an elderly population, who as a group are remarkably het-
erogeneous with regard to their health and life-style char-
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acteristics. The elderly are likely to be at increased risk for
complications associated with various diagnostic and ther-
apeutic procedures and often, appropriately, have quite dif-
ferent expectations concerning the outcomes of their illness.
It was also felt that more basic health information, including
data on prevention, diagnosis and treatment of coronary
heart disease, was needed about this rapidly increasing seg-
ment of our society.
Additional issues raised at that NHLBI conference were:
whether the traditional risk factors for coronary heart disease
determined in younger populations have similar predictive
power in the elderly; whether nutritional and exercise guide-
lines should differ from those for younger people; whether
the benefit conveyed by drugs used to treat coronary heart
disease are of similar value in the aged as in the young;
whether the quality of life is not more important than the
additional length of life in the elderly; and whether one can
or should justify upper age limits for such therapeutic pro-
cedures as coronary bypass surgery or percutaneous trans-
luminal coronary angioplasty, or for various preventive ap-
proaches appropriate with younger populations. As a
consequence of this working conference, as well as related
activities, the NHLBI sees a continuing need to initiate and
support research in coronary heart disease in the elderly.
We now look forward with excitement and interest to the
deliberations and recommendations of this broader scope
Bethesda Conference.
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Introductory Remarks. II
LOT B. PAGE, MD
National Institute on AKinK. National Institutes of Health
I am happy to greet you on behalf of the National Institute
on Aging and its Director, Dr. T. Franklin Williams. It is
very appropriate and timely that "Cardiovascular Disease
in the Elderly" is the subject of this year's Bethesda Con-
ference. The United States, and indeed the entire industrial-
ized world, is experiencing a demographic explosion in the
upper decades of age. The rapid current increase in numbers
of older persons in society is unprecedented in history and
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is progressively accelerating. Well over half of all persons
in the history of the world who have ever reached the age
of 65 years are alive today.
Latest figures for the U.S. show that life expectancy for
children born in the early 1980s is 70.8 years for males and
78.2 years for females. For persons who reached the age
of 65 in 1985, an average life expectancy of 15.1 additional
years is predicted for men and 19.5 additional years for
women.
In 1985 there were 28.6 million persons aged ;::::65 years,
representing 11.9% of the U.S. population. Projections for
future demographic trends depend on varying assumptions.
"Mid-range" projections, made in 1984, indicate that in
the year 2030 there will be 34.9 million persons aged ;::::65
years, representing 21.1 % of the U.S. population or almost
double the present proportion. The fastest growing segment
of our population are those aged ;::::85 years. At present there
are approximately 2.7 million of these "oldest-old," and
they are projected to increase by nearly sixfold, reaching
almost 16 million by the year 2030.
These demographic shifts are truly dramatic and the con-
sequences to our society will be profound. Despite general
downward trends in cardiovascular mortality, by far the
leading cause of death and disability in the elderly is car-
diovascular disease, and the cardiovascular risk increases
steadily with age.
Life inevitably ends in death. As physicians, our goal
for the elderly should not be the indefinite extension of life;
for this group, the prevention of enfeeblement, disability
and dependence is the dominant health objective. As a new
recruit to the field of aging research, I look forward with
great interest to participating with you in discussion of these
important topics.
Introductory Remarks. III
NANETTE K. WENGER, MD, FACC
Chair, 18th Bethesda Conference
The elderly represent the most rapidly growing group in the
nation; about 5,500 individuals reach their 65th birthday
each day. The preponderance of our elderly population is
reasonably healthy, lives independently in the community
and is adequately functional-despite a greater than 80%
prevalence of at least one chronic illness. Many elderly
persons look and feel younger than their chronologie age.
Some continue at remunerative work and most look forward
to an extended and active retirement. Thus, preventive ef-
forts are most appropriate to include in medical planning.
The elderly are, however, a highly heterogeneous group
in all respects except their chronologie age. Chronologie
age is a poor predictor of functional capability. As Pascal
stated, "Old age is just a time that is farther from the
beginning and nearer to the end."
Nevertheless, the 12% of the population >65 years of
age currently uses 30% of our national health resources.
Some 1.3 million elderly persons reside in nursing homes,
at an annual cost exceeding $13 billion. The elderly are also
disproportionately high consumers of drugs, with this 12%
of the population taking 25% of all drugs. Because drug
interactions increase logarithmically and are further accen-
tuated by the multisystem decrease in function with aging,
appropriate pharmacotherapy, in appropriate dosage, must
be prescribed with care.
Our goals for this Conference are multiple and our target
audiences varied. Many of our conclusions and recommen-
dations are designed to help physicians and other health
professionals who care for elderly patients with cardiac dis-
ease; many are designed for elderly cardiac patients them-
selves; and many are designed for society: both the general
public, including the elderly, and society's elected repre-
sentatives, the individuals who formulate and promulgate
public policy.
In a recent article in the Journalof theArnericanGeriatric
Society (1) advice was given that the physician "who vol-
untarily undertakes to deliver services to an older population
also voluntarily undertakes, explicitly or implicitly, to de-
velop and maintain a significant data base on the physical,
mental, psychologic, social, economic, legal and spiritual
realities of aging in contemporary America. "
Thus, at this Conference, to assemble a contemporary
data base on cardiovascular disease in the elderly for the
medical community, we plan to identify the features of
biologic aging that are associated with the cardiovascular
system as contrasted with those that are associated with
disease. For a number of specific cardiovascular disorders
and their manifestations we plan to define those character-
istics unique to the elderly and to provide reasonable di-
rection for the appropriate recognition and management of
specific cardiovascular illnesses. Equally important will be
delineation of the information that is yet needed to provide
quality cardiovascular care for elderly persons, information
that will likely require both basic and clinical research. So
many decisions made in the care of elderly patients are based
on data extrapolated from younger populations. We further
hope to identify those clinical features and approaches that
suggest or increase the likelihood of a favorable outcome.
But medical care does not take place in a vacuum. On
the one hand, we are the beneficiaries of unprecedented
scientific developments, with major advances made in health
